Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPTIMAL: Postoperative Antibiotic Management Duration Following Surgery for IVDA Endocarditis
NCT05156437Phase 4Terminated
- Sponsor
- West Virginia University
- Start
- Mar 2022
- Primary completion
- Oct 2024
- Modality
- Irreversible Covalent Inhibitors, Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of amoxicillin, cefalexin, dicloxacillin, linezolid, levofloxacin in endocarditis (IE), sponsored by West Virginia University. Started Mar 2022; status: terminated.
02
Drugs
amoxicillincefalexindicloxacillinlinezolidlevofloxacin
03
Conditions
endocarditis (IE)
Beyond the preview
Go deeper on NCT05156437.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05156437.